CHARLES SCHWAB INVESTMENT MANAGEMENT INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,012,499
+17.4%
983,009
+32.2%
0.00%
Q2 2023$862,552
-21.9%
743,579
+1.7%
0.00%
Q1 2023$1,104,000
-44.7%
731,126
-8.4%
0.00%
-100.0%
Q4 2022$1,995,113
-36.2%
798,045
+7.7%
0.00%0.0%
Q3 2022$3,128,000
+53.3%
741,006
+1.4%
0.00%0.0%
Q2 2022$2,040,000
-50.1%
731,055
+2.2%
0.00%0.0%
Q1 2022$4,092,000
-35.6%
715,306
+2.7%
0.00%
-50.0%
Q4 2021$6,357,000
-14.6%
696,257
-0.0%
0.00%0.0%
Q3 2021$7,446,000
-24.7%
696,526
+9.3%
0.00%
-33.3%
Q2 2021$9,894,000
+7.1%
637,446
+11.9%
0.00%0.0%
Q1 2021$9,234,000
-21.2%
569,611
+2.9%
0.00%
-40.0%
Q4 2020$11,720,000
+45.6%
553,741
+2.0%
0.01%
+25.0%
Q3 2020$8,049,000
+1.4%
543,084
+0.6%
0.00%0.0%
Q2 2020$7,941,000
+35.7%
539,836
+8.3%
0.00%
+33.3%
Q1 2020$5,852,000
-49.4%
498,460
+1.4%
0.00%
-50.0%
Q4 2019$11,557,000
+46.4%
491,775
+15.3%
0.01%
+20.0%
Q3 2019$7,893,000
+1.6%
426,613
+2.1%
0.01%0.0%
Q2 2019$7,766,000
-19.8%
417,738
+5.4%
0.01%
-16.7%
Q1 2019$9,684,000
-2.2%
396,219
+3.9%
0.01%
-25.0%
Q4 2018$9,897,000
-17.5%
381,505
+0.6%
0.01%0.0%
Q3 2018$11,997,000
-6.1%
379,045
+15.2%
0.01%
-11.1%
Q2 2018$12,781,000
+71.5%
328,981
+21.8%
0.01%
+50.0%
Q1 2018$7,453,000
+69.5%
270,016
+11.1%
0.01%
+100.0%
Q4 2017$4,398,000
+68.9%
242,934
+50.7%
0.00%
+50.0%
Q3 2017$2,604,000
+10.2%
161,199
-5.5%
0.00%0.0%
Q2 2017$2,363,000
-7.1%
170,555
+0.6%
0.00%
-33.3%
Q1 2017$2,543,000
+61.3%
169,529
+40.9%
0.00%
+50.0%
Q4 2016$1,577,000
-27.5%
120,318
-4.7%
0.00%
-33.3%
Q3 2016$2,176,000
+7.8%
126,268
+13.0%
0.00%0.0%
Q2 2016$2,018,000
+3.2%
111,768
+8.5%
0.00%0.0%
Q1 2016$1,956,000
-27.4%
102,996
+2.1%
0.00%
-25.0%
Q4 2015$2,694,000
+25.2%
100,892
+14.5%
0.00%
+33.3%
Q3 2015$2,151,000
+54.9%
88,116
+97.7%
0.00%
+50.0%
Q2 2015$1,389,000
+133.1%
44,560
+8.8%
0.00%
+100.0%
Q1 2015$596,000
+45.4%
40,950
+0.5%
0.00%0.0%
Q4 2014$410,000
+20.6%
40,7500.0%0.00%0.0%
Q3 2014$340,000
-3.4%
40,750
+43.0%
0.00%0.0%
Q2 2014$352,00028,5000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders